Freeline Therapeutics Holdings plc Severance Costs
Freeline Therapeutics Holdings plc reported Severance Costs of $2.37 million for the 9-month period ending 2022-09-30, per its 6-K filed 2022-11-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2022-11-15
- Freeline Therapeutics Holdings plc severance costs for the quarter ending 2022-09-30 was $0.00.
- Freeline Therapeutics Holdings plc severance costs for the quarter ending 2022-06-30 was $0.00.
- Freeline Therapeutics Holdings plc severance costs for the quarter ending 2022-03-31 was $2.37M.
| Period end | Severance Costs 3 month | Severance Costs 6 month | Severance Costs 9 month |
|---|---|---|---|
| 2022-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2022-11-15 | $0.00 derived: sum of 2 quarters · filed 2022-11-15 | $2.37M 6-K · filed 2022-11-15 |
| 2022-06-30 | $0.00 derived: 6-K 6 month − 6-K 3 month · filed 2022-08-09 | $2.37M 6-K · filed 2022-08-09 | |
| 2022-03-31 | $2.37M 6-K · filed 2022-05-10 |